Using data from the selected studies, contact frequency was plotted against HbA1c reduction and endpoint insulin dose.
In comparison, an analysis was conducted using data from the National Health and Nutrition Examination Survey NHANESS) to assess diabetes prevalence and therapeutic target achievement for US patients using diet and exercise, oral antihyperglycaemic medications and/or insulin.
Her hardware uses data from the insulin pump (which has a tubing that injects insulin into the blood) and the continuous glucose monitor, which calculates blood-glucose levels to calculate and assign new basal rates (the amount of insulin that's set to be pumped into the blood stream every hour) that can override a patient's standard basal rate for a certain amount of time to adjust.
In one study (8), we used data from the multivariable model with full control for potential confounders but not for insulin and glucose because magnesium plays an important role in insulin action and glucose homeostasis (5), and adjustment for insulin and glucose, therefore, could represent overadjustment for variables on the causal pathway.
We used data from the Boston Area Community Health BACH Surveyey to examine racial/ethnic differences in receipt of insulin and oral hypoglycaemic drugs for type 2 diabetes.
In the present study, to further evaluate the consequences of insulin switching, we used data from patients' medical records to investigate retrospectively the real-world clinical outcomes for patients with T2DM who switched between these two basal insulin analogues.
The purpose of this investigation was to use data from continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) together to evaluate the glycemic profiles of missed insulin boluses for afternoon snacks.
Our system uses data from patient logbooks to generate a dose adjustment for each insulin injection.
Uses data from the Framingham Heart Study.
The data of plasma insulin (INS) measured by RBM were calibrated using insulin data from a subset of serum samples measured by a solid-phase, two-site chemiluminescent immunometric assay (Siemens Medical Solutions Diagnostics, Ballerup, Denmark) using an Immulite 2500 analyzer.
